|
|
|
|
|
by orintorynchus
1623 days ago
|
|
The system is constantly learning, so it "retunes" itself. We can infer epitopes from structure, but we found that data derived from known complexes is sufficient for our purpose. Current version of EWS does not explicitly account for glycosylation. It is implicitly handled by the ML models, though. For specificity, it is difficult to estimate. We know that for each of the named Variants of Concern, the signal from EWS was unmissable. Considering, that any new vaccine would need to go through a stringent approval process, I don't think that EWS should be a major determining factor in the process. However, it can certainly help resolve the doubts. |
|
I guess for the glycosylation when you say it’s implicitly handled, there’s a N-linked sequon pattern somewhere in the language model, which I guess covers a good deal of info :)
Jury still out on effects of O-linked glyco on spike, but give me a shout if you’re interested in it!
Anyway, cool work, and all the best in where you’re taking the work next!